Immunogenic ferroptosis and where to find it?

Area of Science:

• Oncology
• Immunology
• Cell Biology

Background:

• Ferroptosis is a distinct form of regulated cell death.
• Its immunogenicity presents novel anticancer therapy opportunities, especially for apoptosis- and necroptosis-resistant cancers.
• However, ferroptotic cells can also promote tumor evasion through immunosuppressive mechanisms.

Purpose of the Study:

• To critically discuss mediators controlling ferroptosis immunogenicity.
• To explore how ferroptosis modulates antitumor immunity.
• To identify the tolerogenic nature of ferroptosis in tumor evasion.

Main Methods:

• Literature review and critical discussion of existing research on ferroptosis and immunogenic cell death.
• Analysis of factors influencing ferroptosis immunogenicity, including oxidized lipids and tumor microenvironment components.
• Exploration of the interplay between ferroptosis, dendritic cell function, and antitumor immunity.

Main Results:

• Early ferroptotic cancer cells exhibit strong immunogenicity, expanding the concept of immunogenic cell death.
• Oxidized lipids in ferroptotic cells can impair phagocytosis and antigen presentation, favoring tumor evasion.
• Tumor microenvironment factors like lactate, acidification, and hypoxia promote ferroptosis resistance and affect immunogenicity.

Conclusions:

• Inducing immunogenic ferroptosis offers a promising strategy for treating resistant cancers.
• Understanding and modulating ferroptosis's dual role in immunity and tolerance is crucial for effective cancer therapy.
• Further research is needed to harness ferroptosis for antitumor immunity while mitigating its immunosuppressive potential.